ID

14149

Beschreibung

Asthma Biomarkers for Predicting Response to Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT01973751

Link

https://clinicaltrials.gov/show/NCT01973751

Stichworte

  1. 01.04.16 01.04.16 -
Hochgeladen am

1. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Asthma NCT01973751

Eligibility Asthma NCT01973751

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01973751
Criteria
Beschreibung

Criteria

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female subjects between the ages of 18 and 70 years
Beschreibung

Age | Gender

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0079399
no respiratory symptoms
Beschreibung

No respiratory symptoms

Datentyp

boolean

Alias
UMLS CUI [1]
C0425443
normal spirometric value and methacholine pd20 >2.5mg
Beschreibung

Spirometry normal | Methacholine

Datentyp

boolean

Alias
UMLS CUI [1]
C0855776
UMLS CUI [2]
C0600370
group b:
Beschreibung

ID.4

Datentyp

boolean

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female subjects between the ages of 18 and 70 years
Beschreibung

Age | Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0079399
history of asthma
Beschreibung

Asthma

Datentyp

boolean

Alias
UMLS CUI [1]
C0004096
no use of oral or inhaled corticosteroids for the treatment of asthma
Beschreibung

Therapeutic procedure | Asthma | Adrenal Cortex Hormones | inhaled steroids

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0004096
UMLS CUI [2]
C0001617
UMLS CUI [3]
C2065041
no use of leukotriene antagonist for the treatment of asthma
Beschreibung

Therapeutic procedure | Asthma | Leukotriene Antagonists

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0004096
UMLS CUI [2]
C0595726
hyperreactivity to methacholine (pd20 fev1 methacholine < 2.5 mg) and/or ≥12% increase in fev1 following inhalation of 200μg salbutamol
Beschreibung

Pulmonary methacholine challenge test | FEV1 | Albuterol

Datentyp

boolean

Alias
UMLS CUI [1]
C1096470
UMLS CUI [2]
C0748133
UMLS CUI [3]
C0001927
asthma symptoms of episodic cough, wheeze and/or breathlessness
Beschreibung

Asthma symptoms | Coughing | Rhonchi | Dyspnea

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C1457887
UMLS CUI [2]
C0010200
UMLS CUI [3]
C0035508
UMLS CUI [4]
C0013404
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
current or former smokers
Beschreibung

Current Smoker | Former smoker

Datentyp

boolean

Alias
UMLS CUI [1]
C3241966
UMLS CUI [2]
C0337671
pregnant women
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
subjects with a history of lung disease other than asthma
Beschreibung

Lung disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0024115
UMLS CUI [2]
C0004096
subjects with a history of a medical disease, which in the opinion of the investigator may put the subject at extra risk from study-related procedures or because the disease may influence the results of the study
Beschreibung

Disease | Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0012634
UMLS CUI [2]
C2348568

Ähnliche Modelle

Eligibility Asthma NCT01973751

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01973751
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Age | Gender
Item
male and female subjects between the ages of 18 and 70 years
boolean
C0001779 (UMLS CUI [1,1])
C0079399 (UMLS CUI [1,2])
No respiratory symptoms
Item
no respiratory symptoms
boolean
C0425443 (UMLS CUI [1])
Spirometry normal | Methacholine
Item
normal spirometric value and methacholine pd20 >2.5mg
boolean
C0855776 (UMLS CUI [1])
C0600370 (UMLS CUI [2])
ID.4
Item
group b:
boolean
Item Group
C1512693 (UMLS CUI)
Age | Gender
Item
male and female subjects between the ages of 18 and 70 years
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Asthma
Item
history of asthma
boolean
C0004096 (UMLS CUI [1])
Therapeutic procedure | Asthma | Adrenal Cortex Hormones | inhaled steroids
Item
no use of oral or inhaled corticosteroids for the treatment of asthma
boolean
C0087111 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2])
C2065041 (UMLS CUI [3])
Therapeutic procedure | Asthma | Leukotriene Antagonists
Item
no use of leukotriene antagonist for the treatment of asthma
boolean
C0087111 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0595726 (UMLS CUI [2])
Pulmonary methacholine challenge test | FEV1 | Albuterol
Item
hyperreactivity to methacholine (pd20 fev1 methacholine < 2.5 mg) and/or ≥12% increase in fev1 following inhalation of 200μg salbutamol
boolean
C1096470 (UMLS CUI [1])
C0748133 (UMLS CUI [2])
C0001927 (UMLS CUI [3])
Asthma symptoms | Coughing | Rhonchi | Dyspnea
Item
asthma symptoms of episodic cough, wheeze and/or breathlessness
boolean
C0004096 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0010200 (UMLS CUI [2])
C0035508 (UMLS CUI [3])
C0013404 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Current Smoker | Former smoker
Item
current or former smokers
boolean
C3241966 (UMLS CUI [1])
C0337671 (UMLS CUI [2])
Pregnancy
Item
pregnant women
boolean
C0032961 (UMLS CUI [1])
Lung disease
Item
subjects with a history of lung disease other than asthma
boolean
C0024115 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
Disease | Study Subject Participation Status
Item
subjects with a history of a medical disease, which in the opinion of the investigator may put the subject at extra risk from study-related procedures or because the disease may influence the results of the study
boolean
C0012634 (UMLS CUI [1])
C2348568 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video